Rho GDP dissociation inhibitor 2 (RhoGDI2) recruits Rac1 to Filamin A (a sizeable cytoskeletal protein), resulting in enhanced interaction between Rac1 and Rho GEF Trio to increase Rac1 activity and promote gastric cancer cell invasion [52]. Here, RAC1 is linked to gastric cancer.